Cost-effectiveness of FDG-PET in staging non-small cell lung cancer: the PLUS study.
Verboom P, van Tinteren H, Hoekstra OS, Smit EF, van den Bergh JH, Schreurs AJ, Stallaert RA, van Velthoven PC, Comans EF, Diepenhorst FW, van Mourik JC, Postmus PE, Boers M, Grijseels EW, Teule GJ, Uyl-de Groot CA; PLUS study group.
Verboom P, et al. Among authors: van velthoven pc.
Eur J Nucl Med Mol Imaging. 2003 Nov;30(11):1444-9. doi: 10.1007/s00259-003-1199-9. Epub 2003 May 29.
Eur J Nucl Med Mol Imaging. 2003.
PMID: 14579081
Clinical Trial.